This is a Validated Antibody Database (VAD) review about human NCR3, based on 24 published articles (read how Labome selects the articles), using NCR3 antibody in all methods. It is aimed to help Labome visitors find the most suited NCR3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
NCR3 synonym: 1C7; CD337; LY117; MALS; NKp30

BioLegend
mouse monoclonal (P30-15)
  • flow cytometry; human; loading ...
BioLegend NCR3 antibody (BioLegend, P30-15) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (P30-15)
  • blocking or activating experiments; human; 10 ug/ml; loading ...; fig 3a
BioLegend NCR3 antibody (Biolegend, 325202) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 3a). elife (2020) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; loading ...; fig 3d
BioLegend NCR3 antibody (BioLegend, 325218) was used in flow cytometry on human samples (fig 3d). J Exp Med (2019) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; loading ...; fig s2a
BioLegend NCR3 antibody (BioLegend, P30-15) was used in flow cytometry on human samples (fig s2a). J Infect Dis (2019) ncbi
mouse monoclonal (P30-15)
  • blocking or activating experiments; human; 10 ug/ml; loading ...; fig s3e
BioLegend NCR3 antibody (BioLegend, P30-15) was used in blocking or activating experiments on human samples at 10 ug/ml (fig s3e). J Cell Biol (2018) ncbi
mouse monoclonal (P30-15)
  • immunohistochemistry; human; 5 mg/ml; loading ...; fig s1b
BioLegend NCR3 antibody (Biolegend, P30-15) was used in immunohistochemistry on human samples at 5 mg/ml (fig s1b). Curr Biol (2018) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; loading ...; fig s3c
BioLegend NCR3 antibody (BioLegend, P30-15) was used in flow cytometry on human samples (fig s3c). J Biol Chem (2018) ncbi
mouse monoclonal (P30-15)
  • mass cytometry; human; loading ...; fig 4f
BioLegend NCR3 antibody (Biolegend, P30-15) was used in mass cytometry on human samples (fig 4f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; mouse; fig 1e
BioLegend NCR3 antibody (BioLegend, 325208) was used in flow cytometry on mouse samples (fig 1e). J Virol (2017) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; loading ...; fig 5a
BioLegend NCR3 antibody (Biolegend, 325208) was used in flow cytometry on human samples (fig 5a). PLoS ONE (2017) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, BioLegend NCR3 antibody (BioLegend, P30-15) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human
BioLegend NCR3 antibody (BioLegend, P30-15) was used in flow cytometry on human samples . J Immunol (2015) ncbi
Beckman Coulter
mouse monoclonal (Z25)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter NCR3 antibody (Beckman Coulter, Z25) was used in flow cytometry on human samples (fig 2a). Front Immunol (2019) ncbi
mouse monoclonal (Z25)
  • flow cytometry; human; loading ...; fig 3c
Beckman Coulter NCR3 antibody (Beckman Coulter, Z25) was used in flow cytometry on human samples (fig 3c). Immun Ageing (2017) ncbi
mouse monoclonal (Z25)
  • flow cytometry; human; loading ...; fig 6c
In order to investigate NF-KB signaling in natural killer cells, Beckman Coulter NCR3 antibody (Beckman Coulter, Z25) was used in flow cytometry on human samples (fig 6c). Nat Commun (2016) ncbi
mouse monoclonal (Z25)
  • flow cytometry; human; loading ...; fig 2g
Beckman Coulter NCR3 antibody (Beckman Coulter, Z25) was used in flow cytometry on human samples (fig 2g). J Leukoc Biol (2016) ncbi
mouse monoclonal (Z25)
  • flow cytometry; human
Beckman Coulter NCR3 antibody (Beckman, Z25) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
BD Biosciences
mouse monoclonal (P30-15)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences NCR3 antibody (BD Pharmingen, P30-15) was used in flow cytometry on human samples (fig 5a). Front Immunol (2019) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences NCR3 antibody (BD Biosciences, p30-15) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; 1:100; fig 1
In order to elucidate the marked reduction of Nkp44/Nkp46-double positive natural killer cells by celiac disease-related inflammation, BD Biosciences NCR3 antibody (Becton Dickinson, p30-15) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences NCR3 antibody (BD, 558407) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; fig 6
BD Biosciences NCR3 antibody (BD Bioscience, 558407) was used in flow cytometry on human samples (fig 6). PLoS ONE (2015) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human
BD Biosciences NCR3 antibody (BD, 558408) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (P30-15)
  • flow cytometry; human; fig s1
BD Biosciences NCR3 antibody (BD Biosciences, p30-15) was used in flow cytometry on human samples (fig s1). J Immunol (2015) ncbi
Articles Reviewed
  1. Hood S, Cosma G, Foulds G, Johnson C, Reeder S, McArdle S, et al. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. elife. 2020;9: pubmed publisher
  2. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed publisher
  3. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed publisher
  4. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  5. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  6. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  7. Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright A, Guldevall K, et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J Cell Biol. 2018;217:3267-3283 pubmed publisher
  8. Carisey A, Mace E, Saeed M, Davis D, Orange J. Nanoscale Dynamism of Actin Enables Secretory Function in Cytolytic Cells. Curr Biol. 2018;28:489-502.e9 pubmed publisher
  9. Cribbs A, Hookway E, Wells G, Lindow M, Obad S, Oerum H, et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018;293:2422-2437 pubmed publisher
  10. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  11. Bar On Y, Charpak Amikam Y, Glasner A, Isaacson B, Duev Cohen A, Tsukerman P, et al. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy. J Virol. 2017;91: pubmed publisher
  12. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed publisher
  13. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  14. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  15. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  16. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed publisher
  17. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed publisher
  18. Rettman P, Willem C, David G, Riou R, Legrand N, Esbelin J, et al. New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells. J Leukoc Biol. 2016;100:471-9 pubmed publisher
  19. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  20. Zou Y, Bao J, Pan X, Lu Y, Liao S, Wang X, et al. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. PLoS ONE. 2015;10:e0134568 pubmed publisher
  21. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  22. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed publisher
  23. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  24. Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M, et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94 pubmed publisher